You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, November 2015
|
| DOI | 10.1186/2051-1426-3-s2-p146 |
| Authors |
Robert Chen, Phillippe Armand, Michelle A Fanale, Vincent Ribrag, Pier Luigi Zinzani, Alejandro D Ricart, Seth Thompson, Arun Balakumaran, Daniel Molin, Margaret A Shipp, Craig H Moskowitz |
Mendeley readers
The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 2 | 67% |
| Student > Doctoral Student | 1 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Economics, Econometrics and Finance | 1 | 33% |
| Immunology and Microbiology | 1 | 33% |
| Medicine and Dentistry | 1 | 33% |